Covid-19

Two die of blood-clotting disorders linked to AstraZeneca vaccine, coroners confirm

Published

4 years ago

March 18, 2022

UK coroners in two separate cases this week concluded individuals who received AstraZeneca’s COVID-19 vaccine died from blood-clotting disorders caused by the vaccine.

Kim Lockwood, a 34-year-old mother from South Yorkshire, died in March 2021 of a catastrophic brain bleed nine days after getting the AstraZeneca shot.

Lockwood complained of an excruciating headache eight days after getting the vaccine. Her condition quickly deteriorated and she was pronounced dead 17 hours after being admitted to the hospital.

South Yorkshire Coroner Nicola Mundy, calling Lockwood “extremely unlucky,” recorded the cause of death as vaccine-induced thrombotic thrombocytopenia (VITT).

Separately, a Sheffield County inquest on Monday concluded Tom Dudley, a 31-year old father of two who received the Astra-Zeneca vaccine on April 27, 2021, died of a vaccine-induced brain hemorrhage on May 14, 2021.

The UK’s National Health Service on May 7, 2021, changed the guidance for the AstraZeneca vaccine, suggesting healthy individuals under 40 should avoid it due to possible blood-clotting complications.

Assistant coroner Tanyka Rawden said that at the time of Dudley’s death the potentially fatal blood-clotting issue “was not a known and recognized complication of this vaccine. It seems to me that the guidelines have been changed,” she said. “They were changed very, very quickly after Tom had his vaccination.”

For both Lockwood and Dudley, the change in recommendations came just weeks too late.

UK Government figures show 437 reported cases and 78 deaths from blood-clotting conditions after an estimated 24.9 million first doses and 24.2 million second doses of the AstraZeneca vaccine.

In April 2021, many European countries, including Germany, France, Italy, and Spain, suspended the use of the AstraZeneca vaccine after experts found dangerous blood clots in some vaccine recipients, according to various news sources.

Research published May 5, 2021, in The BMJ confirmed evidence of blood clotting and found a small risk after receiving just one dose of AstraZeneca’s vaccine.

“We did, however, observe an increased rate of venous thromboembolic events, corresponding to 11 excess venous thromboembolic events per 100,000 vaccinations and including a clearly increased rate of cerebral venous thrombosis with 7 observed events versus 0.3 expected events among the 282,572 vaccine recipients.”

According to the latest available VAERS data, between Dec. 14, 2020, and March 4, 2022, there were 5,992 reports of blood-clotting disorders after the Pfizer vaccine, and 4,784 reports following the Moderna vaccine.

Of the total reports of blood-clotting disorders during that time period, 22% of the total number of reports (13,428, including J&J, Pfizer and Moderna) were among individuals 17 to 43 years old; 34.8% among individuals 44 to 64 years old; and 32% among individuals 65 years or older, suggesting the issue is not limited to adults under 40.

Culled from The Defender